Resources
For the latest in nextgen biomed, sign up for our monthly newsletter to be among the first to receive exclusive insights, in-depth market analyses, and expert articles directly to your inbox

See how top pharma players are addressing impure, unstable, and off-target oligos

Boosting the Efficacy of Safe, Scalable, & Precise Vaccines
Innovations in mRNA Technology, RNA Therapeutics, and Cancer Immunotherapy for 2024
.png)
Tumbler: A Highly Customizable Antibody Optimization Suite
On-demand presentation, presented by Michali Izhaky, Bioinformatics Scientist at Charles River

Leading Innovations in Fab, ScFv, & VHH Production and Engineering
On-demand webinar presented by Dr Jiansheng Wu, Head of Protein Sciences and Vice President at WuXi Biologics

Advancing Immunotherapy: The Critical Role of GMP-Grade Cytokines in Cell Therapy
On-demand webinar presented by Ritwika Biswas, Field Application Scientist at Sino Biological

Optimizing Bispecific Antibody Production: From Identifying Optimal Pairings to Scale-up Processes
On-demand webinar presented by Dr Jiansheng Wu, Head of Protein Sciences and Vice President at WuXi Biologics

Unlocking the Future of Immune Cancer Therapy
A concise report featuring insights from the prominent though leaders of Immuno 2024.

Immuno-Oncology
Preclinical Strategies for Combination Immunotherapies
Oncology is almost always oriented towards simultaneous treatment options. We explore why as well as the approach’s unique challenges.

Bioanalysis
The Black Box Effect - How Can AI and ML Provide Transparent Insights for Drug Discovery?
We interview Martin Akerman, Chief Technology Officer and Co-Founder at Envisagenics to find out about machine learning for drug target discovery in RNA.

Peptide Chemistry
Migraine Drug Doubles its Sales, Despite Expansion Setback
Vyepti is the first intravenous medication approved for migraine treatment.

Vaccines
Will Vaccine Manufacturers go into Overdrive this Flu Season?
With influenza expected to make a return this winter, vaccine manufacturers may be facing more demand than usual.

Children in London to be Given Urgent Polio Booster Vaccine
Children between one and nine years old to be given polio jab to curb the spread of the virus throughout the city.

Manufacturing & Bioprocessing
In Conversation With Jenny Prange, Head of GMP Production, Chief Scientific Officer and Co-Founder of Muvon Therapeutics
The present and the future, key insights into the cell and gene therapy manufacturing space

China Warns of New Virus Transmitted by Shrews
How worrying is the new ‘Langya’ virus spreading in China?

Monkeypox Cases in UK Begin to Plateau
Statistics show that the number of people infected with the monkeypox virus is starting to slow down.

Antibody & Protein Engineering
AstraZeneca Suffers Sales Decline for COVID Med Evusheld
A 24 million loss has been reported for the preventative COVID-19 treatment.

Antibody & Protein Engineering
Market Battle for Rare Disease Treatment
Argenx and AstraZeneca are set to become market rivals in their general myasthenia gravis (gMG) treatments, analysts claim.

Immuno-Oncology
AAV Gene Therapy and CAR T Therapies: Immunogenicity and Immunoassay Development
Dr. Vibha Jawa, Executive Director, Nonclinical Disposition and Bioanalysis at BMS
Subscribe to Our Newsletter
Sign up for our monthly newsletter to
keep up with all things discovery